Ventas, Inc. (NYSE:VTR) Receives $90.47 Average Price Target from Analysts

Shares of Ventas, Inc. (NYSE:VTR) have received a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $90.4667.

Several equities research analysts have recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price objective on shares of Ventas in a report on Monday, February 9th. Royal Bank Of Canada raised their target price on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. Argus set a $88.00 target price on shares of Ventas in a report on Tuesday, February 10th. Wells Fargo & Company upped their price target on shares of Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research report on Thursday, March 26th. Finally, UBS Group reiterated a “neutral” rating and issued a $85.00 price target on shares of Ventas in a report on Monday, February 9th.

Ventas Price Performance

VTR stock opened at $83.75 on Wednesday. The business has a 50 day moving average price of $84.70 and a 200 day moving average price of $79.51. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a market cap of $39.82 billion, a price-to-earnings ratio of 155.09, a PEG ratio of 2.04 and a beta of 0.75. Ventas has a fifty-two week low of $61.76 and a fifty-two week high of $88.36.

Ventas (NYSE:VTR) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the company posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts anticipate that Ventas will post 3.85 earnings per share for the current fiscal year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio (DPR) is presently 385.19%.

Insider Buying and Selling

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. The trade was a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. The trade was a 32.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cloud Capital Management LLC purchased a new position in Ventas in the third quarter valued at about $25,000. GoalVest Advisory LLC acquired a new position in shares of Ventas in the 4th quarter valued at approximately $26,000. Wiser Advisor Group LLC acquired a new position in shares of Ventas in the 3rd quarter valued at approximately $27,000. True Wealth Design LLC boosted its stake in shares of Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after buying an additional 405 shares during the last quarter. Finally, IFC & Insurance Marketing Inc. purchased a new position in shares of Ventas during the 4th quarter valued at approximately $30,000. 94.18% of the stock is owned by hedge funds and other institutional investors.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.